Abstract: The present disclosure provides antibodies and antigen binding fragments thereof that bind to an epitope within an interleukin-3 receptor ?.

Abstract: The present disclosure relates to compounds that are able to bind to an interleukin (IL)-3R? chain and neutralize IL-3 signalling and uses thereof.

Abstract: Methods and apparatuses for authentication and/or provisioning of wireless network devices, and in particular, methods and apparatuses for authentication and/or provisioning of wireless network devices that are communicating with and may be monitored and/or controlled by a remote (e.g., cloud) server.

Abstract: The present disclosure provides proteins comprising antigen binding sites of antibodies that bind to interleukin-11 (IL-11) receptor alpha (IL-11R?) and uses thereof, e.g., in therapy.

Abstract: Methods and apparatuses for authentication and/or provisioning of wireless network devices, and in particular, methods and apparatuses for authentication and/or provisioning of wireless network devices that are communicating with and may be monitored and/or controlled by a remote (e.g., cloud) server.

Abstract: Methods and apparatuses for authentication and/or provisioning of wireless network devices, and in particular, methods and apparatuses for authentication and/or provisioning of wireless network devices that are communicating with and may be monitored and/or controlled by a remote (e.g., cloud) server.

Abstract: The present disclosure provides proteins comprising antigen binding sites of antibodies that bind to interleukin-11 (IL-11) receptor alpha (IL-11R?) and uses thereof, e.g., in therapy.

Abstract: Methods and apparatuses for authentication and/or provisioning of wireless network devices, and in particular, methods and apparatuses for authentication and/or provisioning of wireless network devices that are communicating with and may be monitored and/or controlled by a remote (e.g., cloud) server.

Abstract: The present disclosure relates to compounds that are able to bind to an interleukin (IL)-3R? chain and neutralize IL-3 signalling and uses thereof.

Abstract: The present disclosure provides antibodies and antigen binding fragments thereof that bind to an epitope within an interleukin-3 receptor ?.

Abstract: The present disclosure provides proteins comprising antigen binding sites of antibodies that bind to interleukin-11 (IL-11) receptor alpha (IL-11R?) and uses thereof, e.g., in therapy.

Abstract: Wireless radio device alignment tools and methods. Described herein are methods for point-to-point alignment of wireless radio devices and alignment tools to assist in aligning wireless radio devices. These alignment tools may automatically or manually receive location information and may use a local compass function to determine a rough or initial alignment and additional tools to provide further (fine) alignment based on calculated and actual signal strength between the two devices being aligned.

Abstract: Methods and apparatuses for authentication and/or provisioning of wireless network devices, and in particular, methods and apparatuses for authentication and/or provisioning of wireless network devices that are communicating with and may be monitored and/or controlled by a remote (e.g., cloud) server.

Abstract: Methods and apparatuses for authentication and/or provisioning of wireless network devices, and in particular, methods and apparatuses for authentication and/or provisioning of wireless network devices that are communicating with and may be monitored and/or controlled by a remote (e.g., cloud) server.

Abstract: The present disclosure provides proteins comprising antigen binding sites of antibodies that bind to interleukin-11 (IL-11) receptor alpha (IL-11R?) and uses thereof, e.g., in therapy.

Abstract: Apparatus, systems, and methods may operate to access electronic content comprising a document file including document content data, digital signature data, and digital signature trust context data including a previously-stored version number. Additional activities may include executing instructions included in a document processing application to access the digital signature trust context data and to obtain a trusted version number from a digital signature trust settings file, comparing the trusted version number with the previously-stored version number, and indicating the previously-stored version number is not current when the previously-stored version number is not greater than or equal to the trusted version number. Additional apparatus, systems, and methods are disclosed.

Abstract: Methods for modulating testosterone levels using selective 11?-HSD1-dehydrogenase, 11?-HSD1-reductase and 11?-HSD2 dehydrogenase modulating compounds are described.

Abstract: Methods for increasing and decreasing male fertility using selective 11?-HSD1-dehydrogenase, 11?-HSD1-reductase and 11?-HSD2 dehydrogenase modulating compounds are described.